Internet-delivered CBT for Adolescents With OCD: A Randomized Controlled Study
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 66
Inclusion Criteria
- age between 12 and 17 years
- a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
- daily access to the internet
- ...
- age between 12 and 17 years
- a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
- daily access to the internet
- ability to read and write Swedish
- Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
- a parent that is able to co-participate in the treatment
- a primary diagnosis of OCD as defined by DSM-5
Exclusion Criteria
- completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
- ongoing substance dependence
- ongoing psychological treatment for OCD or another anxiety disorder
- ...
- completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
- ongoing substance dependence
- ongoing psychological treatment for OCD or another anxiety disorder
- diagnosed autism spectrum disorder, psychosis or bipolar disorder, severe eating disorder
- suicidal ideation
- subject not able to read or understand the basics of the ICBT material
Summary
- Conditions
- Obsessive Compulsive Disorder
- Obsessive-Compulsive Disorder
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 12 years and 17 years
- Gender
- Both males and females
Description
The primary objective of this study is to test the efficacy of Internet-delivered cognitive behavior therapy (ICBT) for adolescents (12 - 17 years) with OCD. We aim to conduct a randomized controlled study with N = 66 participants. Participants will be randomly assigned to ICBT or a wait list condit...
The primary objective of this study is to test the efficacy of Internet-delivered cognitive behavior therapy (ICBT) for adolescents (12 - 17 years) with OCD. We aim to conduct a randomized controlled study with N = 66 participants. Participants will be randomly assigned to ICBT or a wait list condition, either lasting 12 weeks. The primary outcome measure is the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Study participants will be followed up 3 and 12 months after treatment. ICBT is expected to yield significantly better symptom reduction than the wait list condition.
Inclusion Criteria
- age between 12 and 17 years
- a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
- daily access to the internet
- ...
- age between 12 and 17 years
- a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale, CY-BOCS
- daily access to the internet
- ability to read and write Swedish
- Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
- a parent that is able to co-participate in the treatment
- a primary diagnosis of OCD as defined by DSM-5
Exclusion Criteria
- completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
- ongoing substance dependence
- ongoing psychological treatment for OCD or another anxiety disorder
- ...
- completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
- ongoing substance dependence
- ongoing psychological treatment for OCD or another anxiety disorder
- diagnosed autism spectrum disorder, psychosis or bipolar disorder, severe eating disorder
- suicidal ideation
- subject not able to read or understand the basics of the ICBT material
Tracking Information
- NCT #
- NCT02191631
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Eva Serlachius, MD, PhD Karolinska Institutet
- Eva Serlachius, MD, PhD Karolinska Institutet